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Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Major physiological stress occurs during cardiac surgery with
cardiopulmonary bypass. This is related to hypothermia and
artificial organ perfusion. Thus, serious gastrointestinal complica 
tions, particularly upper gastrointestinal bleeding, sometimes
follow cardiac surgery. We have compared the antisecretory effects
of a preanesthetic H2 antagonist (roxatidine, cardiopulmonary
bypass H2 group, n = 15) and a proton pump inhibitor (rabeprazole,
cardiopulmonary bypass PPI group, n = 15) in patients undergoing
cardiac surgery with cardiopulmonary bypass, and also compared
in patients undergoing a off pump coronary artery bypass graft
surgery (off pump cardiopulmonary bypass H2 group, n = 15).
Gastric pH (5.14 ± 0.61) and gastric fluid volume (13.2 ± 2.4 mL)
at the end of surgery in off pump cardiopulmonary bypass H2
groups was significantly lower and higher than those in both
cardiopulmonary bypass H2 (6.25 ± 0.54, 51.3 ± 8.0 mL) and cardio 
pulmonary bypass PPI (7.29 ± 0.13, 63.5 ± 14.8 mL) groups, respec 
tively although those variables did not differ between groups
after the induction of anesthesia. Plasma gastrin (142 ± 7 pg/mL)
at the end of surgery and maximal blood lactate levels (1.50 ±
0.61 mM) in off pump cardiopulmonary bypass H2 group were also
significantly lower than those in both cardiopulmonary bypass H2
(455 ± 96 pg/mL, 3.97 ± 0.80 mM) and cardiopulmonary bypass PPI
(525 ± 27 pg/mL, 3.15 ± 0.44 mM) groups, respectively. In addition,
there was a significant correlation between gastric fluid volume
and maximal blood lactate (r = 0.596). In conclusion, cardio 
pulmonary bypass may cause an increase in gastric fluid volume
which neither H2 antagonist nor PPI suppresses. A significant
correlation between gastric fluid volume and maximal blood
lactate suggests that gastric fluid volume may predict degree of
gastrointestinal tract hypoperfusion.
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Introduction Major physiological stress occurs during cardiac surgery with
cardiopulmonary bypass (CPB). This is related to hypo-
thermia and artificial organ perfusion. Several studies show that
serious gastrointestinal complications, particularly upper gastro-
intestinal (GI) bleeding, follow cardiac surgery and these compli-
cations can lead to high rates of morbidity and mortality.(1,2) In
addition, Ueki and colleagues(3) reported that secretion of gastric
juice increased significantly from 3.8 ± 1.3 to 12.4 ± 4.0 ml/h
after induction of extracorporeal circulation. Thus, a risk for acid
aspiration pneumonia may increase after CPB.
Aspirin and anti-platelet drugs are commonly used for patients
with coronary heart disease. Proton pump inhibitor (PPI) and H2
antagonists are recommended for the prevention of nonsteroidal
antiinflammatory drugs (NSAIDs)-related ulcer.(4) However, long-
term H2 antagonist medication produces a reduction in anti-
secretory efficacy or tolerance.(5,6) We have previously reported
that patients receiving H2 antagonists for more than 4 weeks show
resistance to preanesthetic H2 antagonist treatment, used for acid
aspiration pneumonia prophylaxis.(7) If patients develop tolerance
then preanesthetic H2 antagonist medication would be essentially
useless and an alternative would be required. In contrast, PPIs may
be a suitable alternative as they produce a similar or more potent
anti-secretory effect on gastric acid secretion than H2 antago-
nists.(8,9) These reports(8,9) also suggest that tolerance to PPI
treatment would not develop as PPIs inhibit the H+/K+-adenosine
triphosphatase pump, which is the final step in gastric acid secre-
tion from the parietal cell.(10)
Thus, we hypothesized that PPI may be more effective for
prophylaxis of perioperartive stress-induced GI bleeding and acid
aspiration pneumonia than H2 antagonist in patients undergoing
cardiac surgeries with CPB. Therefore, in the present study, to test
our hypothesis, we have compared the antisecretory effects of a
preanesthetic H2 antagonist (roxatidine) and a PPI (rabeprazole) in
patients undergoing cardiac surgery and also compared gastric pH
and volume in patients with and without CPB.
Materials and Methods
With University Ethics Committee approval and informed
consent, 45 adult patients undergoing cardiac surgery were
recruited in the study. Number of patients in each group was
determined by power analysis using our previous study data.(5)
Thirty patients undergoing cardiac surgery under CPB were
randomly assigned to two groups: CPB-H2 and CPB-PPI group
(n = 15 each). Another 15 patients were scheduled to undergoing
off-pump coronary artery bypass grafting (OPCAB) surgery
(OPCAB-H2 group). In the CPB-H2 and OPCAB-H2 groups,
patients were given roxatidine 75 mg orally at 9:00 pm on the
day before the surgery and 2 h before the induction of anesthesia.
In the CPB-PPI group, patients were premedicated with rabepra-
zole 20 mg orally at 9:00 pm on the day before the surgery and 2 h
before the induction of anesthesia. Because only roxatidine has
been approved as an oral preanesthetic H2 antagonist by our
Ministry of Health, Labor and Welfare in Japan, famotidine or
ranitidine was not used. All patients were hospitalized for at least
the night before surgery and were fasted from the first anesthetic
premedication (i.e., 9:00 pm). The researchers and patients were
blinded to preanesthetic medication.
Anesthesia was induced with propofol 0.5–1.5 mg/kg, ketamine
0.5–1.0 mg/kg, and fentanyl 5 µg/kg and maintained with propofol
3–7 mg·kg−1·h−1, ketamine 0.5–1.0 mg·kg−1·h−1, and fentanyl 4–8
µg/kg. The trachea was intubated after muscle relaxation facili-
tated with vecuronium 0.1 mg/kg IV. Muscle relaxation was
maintained with an IV bolus of vecuronium that was given 1 mg
every 30 min. A gastric tube (Argyle® Salem Sump Tube, Japan
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Sherwood, Tokyo, Japan) was placed into the stomach twice after
tracheal intubation and the end of surgery as the first gastric tube
was removed before insertion of transesophageal echocardio-
graphy probe. The position of tip of gastric tube was verified by
auscultation of the epigastrium during insufflation of air.
Gastric fluid was obtained by aspiration using a 10 or 50 mL
syringe while changing the patient’s position (supine, Trendelen-
burg and reverse Trendelenburg, and right and left 20 degree
semilateral positions) and with insufflation of 50 mL air plus
upper-abdominal massage. The volume of gastric contents was
recorded as well as the pH value, measured using a pH meter with
0.01 pH unit precision over the entire pH range (Ecoscan pH5
pH6; Iuchi Seieido Co., Ltd., Osaka, Japan) that was calibrated
each morning.
Arterial blood was collected simultaneously and centrifuged at
3,000 rpm for 10 min at −10°C to separate plasma, which was kept
frozen at −70°C until assay. Plasma gastrin concentrations were
analyzed using a commercially available enzyme-linked immuno-
sorbent assay (Peninsula Laboratories Inc., San Carlos, CA) with
a minimum sensitivity, inter- and intraassay coefficient of variation
of 7.27 pg/mL, 6.5% and 3.7%, respectively. In addition, arterial
blood lactate levels were measured every hour.
Data are presented as mean ± SEM. Statistical analysis was
performed using factorial or repeated one way ANOVA and paired
or unpaired t test as appropriate, with p<0.05 considered significant.
Results
There were no significant differences between groups with
respect to sex, age, height, and weight except duration of anesthesia
and surgery. These data are summarized in Table 1. The type of
cardiac surgery is also listed in Table 2.
Gastric pH and volume at the end of surgery in OPCAB-H2
groups was significantly lower and higher than those in both CPB-
H2 and CPB-PPI groups, respectively although those variables did
not differ between groups after the induction of anesthesia
(Fig. 1 A and B). Plasma gastrin and maximal blood lactate levels
were also significantly lower in OPCAB-H2 group than those in
both CPB-H2 and CPB-PPI groups (Fig. 1 C and D). In addition,
there was a significant correlation between gastric fluid volume
and maximal blood lactate level (Fig. 2; r = 0.596; p<0.01).
There were fewer patients showing critical factors for acid
aspiration pneumonia (pH<2.5 or gastric fluid volume>25 mL) in
the OPCAB-H2 group (Table 3).
Discussion
CPB patients (CPB-H2 and CPB-PPI groups) had higher gastric
pH and volume compared to those in the OPCAB-H2 group. If H2
antagonist and PPI were effective, gastric fluid volume should
have been reduced with higher pH. Thus, higher gastric pH may
not imply that these anti-acid agents suppressed gastric acid
secretion. Where did gastric fluid volume come from? Several
reports(11–14) indicate that the CPB causes intestinal hypoperfusion
which impairs small intestinal transport and increases intestinal
permeability. Tsunooka and colleagues(14) reported that serum
diamine oxidase activity, an index of small intestinal ischemia,
rose significantly during the CPB in patients undergoing coronary
artery bypass grafting. The activity was unchanged in patients
undergoing OPCAB. In addition, serum lactate mirrored the
changes in diamine oxidase activity. Similarly, blood lactate was
significantly higher in the CPB groups than that in the OPCAB
group in the present study. As lactate production increases as a
consequence of tissue hypoxia, high blood lactate levels may also
indicate intestinal hypoperfusion during CPB.(14) As there was a
significant correlation between gastric fluid volume and maximal
blood lactate levels in the present study, intestinal hypoperfusion
due to CPB could increase GI microvascular permeability to
increase gastric fluid volume. Therefore, either gastric fluid
volume or blood lactate may be an index of GI tract hypo-
perfusion.
Critical factors for acid aspiration pneumonia in adults have
been considered to comprise gastric pH below 2.5 and a fluid
volume above 25 mL.(15) In the present study, 12 and 10 of 15
patients with more than 25 mL of gastric contents in the CPB-H2
and CPB-PPI groups have a higher postoperative risk of acid
aspiration pneumonia. Into the OPCAB-H2 group only 2 of 15
patients had gastric contents in excess of 25 mL. Thus, gastric tube
should be inserted after removal of transesophageal echocardio-
graphic probe.
To determine the precise mechanism regarding the increase of
gastric fluid volume by CPB, we should have placed the gastric
tube just after termination of CPB rather than just before the end
Table 1. Patient characteristics
Data are either number of patients or Mean ± SD as appropriate. Ht: height, Wt: weight, Ane: anesthesia, Surg: surgery, CPB: cardiopulmonary by 
pass, (—): no application, *p<0.01 vs OPCAB H2.
Group n Sex 
(M/F)
Age 
(yr)
Ht 
(cm)
Wt 
(kg)
Duration (min)
Ane Surg CPB
CPB H2 15 4/11 60 ± 12 157 ± 10 56 ± 14 439 ± 88* 357 ± 84* 189 ± 61
CPB PPI 15 7/8 64 ± 11 158 ± 96 4 ± 11 441 ± 146* 372 ± 141* 200 ± 103
OPCAB H2 15 5/10 67 ± 10 157 ± 96 0 ± 10 342 ± 57 273 ± 55 (—)
Table 2. Details of cardiac procedures
CABG: coronary artery bypass grafting, ope: operation, MVR: mitral
valve replacement, MVP: mitral valve plasty, AVR: aortic valve replace 
ment, TAP: tricuspid annuloplasty, TVR: tricuspid valve replacement,
ASD: atrial septal defect, VSD: ventricular septal defect, As Ao: ascend 
ing aorta, Ds Ao: descending aorta, (—): no application.
Type of cardiac surgery
Group
CPB H2 CPB PPI OPCAB H2
CABG 1 1 15
CABG + Dor’s ope 2 0 (—)
CABG + Dor’s ope + MVP 1 0 (—)
C A B G+A V R 2 4 ( — )
CABG + MVP 1 1 (—)
AVR 1 1 (—)
TVR 1 0 (—)
MVR or MVP 4 1 (—)
MVR + TAP 2 0 (—)
MVR + AVR 0 1 (—)
ASD 0 1 (—)
ASD + VSD 0 1 (—)
ASD + MVP 0 1 (—)
As Ao Replacement + AVR 0 1 (—)
Ds Ao Replacement 0 1 (—)
Total Arch Replacement 0 1 (—)doi: 10.3164/jcbn.10 101
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of surgery in the present study. However, as OPCAB-H2 group
data clearly suggest that an increase in gastric fluid volume may be
due to CPB as cardiac surgery per se would not increase gastric
fluid volume.
The present data indicate that both H2 antagonist and PPI cannot
inhibit an increase in gastric fluid volume. Should these agents be
given as anesthetic premedication? If neither are given, most of
patients would have a high risk of acid aspiration pneumonia
during the induction of anesthesia as we previously found that
patients without prophylaxis showed low gastric pH (2.2 ± 1.2)
and high volume (20 ± 18 mL).(16) In addition, the chief GI
complication following CPB is GI bleeding secondary to gastric
or duodenal ulceration.(17) Therefore, perioperative gastric acid
suppression is necessary. Which anti-acid agent is suitable to
suppress gastric acidity in patients undergoing cardiac surgery
H2 antagonist or PPI? Wagner and colleagues(15) reported that
perioperative administration of famotidine (H2 antagonist) sup-
presses gastric secretion in cardiac patients. Hata and colleagues(18)
compared three agents (n = 70 each): teprenone 150 mg/day
(mucosal protection), ranitidine 300 mg/day (H2 antagonist) and
rabeprazol 10 mg/day (PPI) to prevent postoperative the upper GI
complicationsin patients undergoing cardiac surgery with CPB.
They found that the incidences of hemorrhagic gastritis and active
ulceration were significantly lower in patients with rabeprazole.
Fig. 1. Changes in gastric pH (A), gastric fluid volume (B), plasma gastrin (C) and maximal blood lactate level (D) at the beginning and end of
surgery. Pre: before cardiopulmonary bypass (CPB), Post: after cessation of CPB, Mean ± SEM, *p<0.01 vs Pre, #p<0.01 vs OPCAB H2 group.
Fig. 2. Correlation between gastric fluid volume and maximal blood
lactate (r = 0.596, p<0.01). J. Clin. Biochem. Nutr. | July 2011 | vol. 49 | no. 1 | 19
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Therefore, preanesthetic PPI may be the most appropriate anti-
acid for patients undergoing cardiac surgery with CPB.
In conclusion, the present study suggests that both gastric fluid
volume and blood lactate level may predict the degree of GI tract
hypoperfusion. As CPB often increases gastric fluid volume more
than 25 mL, gastric tube should be placed before the end of
surgery.
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CPB cardiopulmonary bypass
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Table 3. Number of patients showing critical factors for acid aspiration pneumonia and hypergastrinemia after induction of
anesthesia (Pre) and the end of surgery (Post)
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CPB H2 Pre 3/15 3/15 6/15 9/15
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Post 0/15 10/15 10/15 12/15
OPCAB H2 Pre 4/15 2/15 5/15 5/15
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